BioScrip, Inc. to Present at Credit Suisse 18th Annual Healthcare Conference

BioScrip's President and Chief Operating Officer, Richard M. Smith, and Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer will present Thursday, November 12th at 5 p.m. Mountain Time (7 p.m. Eastern Time).

Investors may access the live audio web cast of BioScrip's presentation at the following link:http://w.on24.com/r.htm?e=174847&s=1&k=E3265C3F7238509602B226468A02E67E. A web cast replay of the presentation may also be accessed via BioScrip’s website at www.bioscrip.com under the Investors Section until Thursday, November 26th.

About BioScrip, Inc.

BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payers and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex health care conditions.

Forward Looking Statements-Safe Harbor

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.

BioScrip, Inc.
Stanley G. Rosenbaum, 952-979-3768
Executive Vice President and Chief Financial Officer
srosenbaum@bioscrip.com
or
In-Site Communications
Lisa M. Wilson, 917-543-9932
lwilson@insitecony.com